Wyeth Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WYETH PHARMS, and what generic alternatives to WYETH PHARMS drugs are available?
WYETH PHARMS has thirty-one approved drugs.
There are six US patents protecting WYETH PHARMS drugs.
There are fifty-six patent family members on WYETH PHARMS drugs in thirty countries and thirty-six supplementary protection certificates in thirteen countries.
Drugs and US Patents for Wyeth Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms | CORDARONE | amiodarone hydrochloride | TABLET;ORAL | 018972-001 | Dec 24, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-003 | Jan 31, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wyeth Pharms | TRECATOR | ethionamide | TABLET;ORAL | 013026-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 050545-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wyeth Pharms | PREMARIN | estrogens, conjugated | TABLET;ORAL | 004782-006 | Jul 16, 2003 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 050545-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Wyeth Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-001 | Oct 25, 1996 | 4,966,768*PED | ⤷ Try a Trial |
Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | 5,210,081 | ⤷ Try a Trial |
Wyeth Pharms | ZOSYN | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050684-001 | Oct 22, 1993 | 8,133,883 | ⤷ Try a Trial |
Wyeth Pharms | PREMPHASE 14/14 | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-002 | Nov 17, 1995 | 5,210,081 | ⤷ Try a Trial |
Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-003 | Jan 9, 1998 | RE36247 | ⤷ Try a Trial |
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-002 | Jan 31, 1991 | 3,939,178 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for WYETH PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 0.09 mg/0.02 mg | ➤ Subscribe | 2007-10-05 |
➤ Subscribe | Delayed-release Tablets | 20 mg and 40 mg | ➤ Subscribe | 2004-02-02 |
➤ Subscribe | Tablets | 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg | ➤ Subscribe | 2005-11-03 |
➤ Subscribe | For Injection | 12 g/1.5 g per vial (pharmacy bulk) | ➤ Subscribe | 2011-12-06 |
International Patents for Wyeth Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Serbia | 20060238 | ⤷ Try a Trial |
Norway | 20061471 | ⤷ Try a Trial |
Australia | 2005233133 | ⤷ Try a Trial |
Costa Rica | 8615 | ⤷ Try a Trial |
Japan | 2009035535 | ⤷ Try a Trial |
Colombia | 5690538 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wyeth Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0802183 | 2009/028 | Ireland | ⤷ Try a Trial | PRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/09/511/001-004 20090417 |
1453521 | 15C0050 | France | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | 300814 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1380301 | CA 2009 00017 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
0503785 | CA 2011 00026 | Denmark | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
1453521 | C201630040 | Spain | ⤷ Try a Trial | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.